Program Overview

About the Ph.D. in Pharmaceutical Health Outcomes and Policy 

Application Deadline: 5:00 p.m. Jan. 10, 2016 - PhD Graduate Admissions page

The Pharmaceutical Health Outcomes and Policy Doctoral degree program at the University of Houston College of Pharmacy offers a learning and research environment that combines the collaborative opportunities of the Texas Medical Center’s world-class healthcare and scientific community with the academic resources and award-winning faculty at Houston’s only Carnegie Institute-designated Tier One public research university.

Pharmaceutical Health Outcomes and Policy consists of pharmaceutical practice and policy research, a multidisciplinary field that examines cost, access, and quality of pharmaceutical care from clinical, sociobehavioral, economic, organizational and technological perspectives. Traditional and innovative areas of pharmaceutical health outcomes research include pharmacoepidemiology, pharmacoeconomics, comparative effectiveness research, patient-centered outcomes research, and translational research.

Program Eligibility

The Ph.D. in Pharmaceutical Health Outcomes and Policy at UH College of Pharmacy requires a minimum of 70 credit hours and successful defense of a doctoral dissertation. Applicants with a pharmacy background and/or advanced training will be given preference, and prospective students with health care-related backgrounds and/or experience are encouraged to apply.


The graduate program offers structured learning and experiences in health care systems, health care quality, health behavior, biostatistics, multivariate analyses, research methods and design, pharmacoepidemiology, and pharmacoeconomics.

Elective courses such as secondary data analyses, multilevel modeling, patient-reported outcomes, and risk adjustments provide advanced learning experiences, along with the opportunities to participate in grant proposal writing and teaching and research practicums.

Graduate courses in healthcare administration and healthcare evaluation and policy also are available from TMC academic institutions, such as The University of Texas School of Public Health and the University of Houston Clear Lake, to provide well-rounded graduate training in pharmaceutical health outcomes and policy.


Within the college’s Department of Pharmaceutical Health Outcomes and Policy, our nine faculty members come from a range of backgrounds, including pharmacoepidemiology, practice-based research, public health, biostatistics, and socio-behavioral and administrative pharmacy.

Among our faculty are recipients of awards and/or research grants from such organizations as the National Institutes of Health, the Agency for Healthcare Research & Quality, the PhRMA Foundation, and Pharmaceutical companies.

Program Dynamics

  • Yearly enrollment on a competitive basis
  • Financial assistance for qualified applicants based on availability
  • Collaboration with Texas Medical Center health care institutions
  • Collaboration with the Pharmaceutical and Pharmacy Industry

Job Opportunities

Pharmaceutical Health Outcomes and Policy graduates are in high demand by the pharmaceutical industry, healthcare consulting groups, pharmacy benefit management companies, healthcare organizations, academia and government/regulatory agencies.